Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen Guidances Underscore FDA Standards Aren’t Changing

Executive Summary

CDER has published guidances, required by the 2014 Sunscreen Innovation Act, on FDA’s process for advisory committees to consider firms’ sunscreen ingredient proposals and on withdrawing pending proposals being considered by the agency.

You may also be interested in...



Consumer Reports Lathers On More Criticism Of Sunscreen SPF Claims

The annual bad marks for sunscreen brands SPF claims from Consumer Reports could be due to CR's nonconformity with FDA-prescribed test guidelines or could signal testing failures or other compliance problems in the industry. In any event, companies retest sunscreen formulas to validate their claims.

Consumer Reports Lathers On More Criticism Of Sunscreen SPF Claims

The annual bad marks for sunscreen brands SPF claims from Consumer Reports could be due to CR's nonconformity with FDA-prescribed test guidelines or could signal testing failures or other compliance problems in the industry. In any event, companies retest sunscreen formulas to validate their claims.

FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review

The agency maintains maximal usage trials are essential in sunscreen ingredient GRASE assessments, despite industry objections that the tests have not been used for UV filters and no protocol is established. FDA’s final guidance closely mirrors its draft issued a year ago, which stakeholders projected would further delay consumer access to updated sunscreen products.

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel